Categories Analysis, Consumer

J.M. Smucker (SJM) anticipated to report mixed results for Q2 2026

SJM expects adjusted EPS in Q2 2026 to decline approx. 25% YoY

Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Monday. The stock has dropped 3% in the past three months. The branded foods company is scheduled to report its earnings results for the second quarter of 2026 on Tuesday, November 25, before market open. Here’s a look at what to expect from the earnings report:

Revenue

J.M. Smucker has guided for sales to increase low-single-digits in the second quarter of 2026. Analysts are projecting revenue of $2.32 billion, which implies a growth of 2% from the same period a year ago. In the first quarter of 2026, sales dropped 1% year-over-year to $2.11 billion.

Earnings per share

SJM expects adjusted earnings per share in Q2 2026 to decline approx. 25% YoY. Analysts are predicting EPS of $2.10 for the quarter, which suggests a decrease of nearly 24% from the year-ago period. In Q1 2026, adjusted EPS decreased 22% YoY to $1.90.

Points to note

SJM’s top line expectations for the second quarter include an impact of $50 million related to the divested Voortman business and certain Sweet Baked Snacks value brands. Comparable sales is expected to increase mid-single-digits in Q2, reflecting an increase in net price realization partly offset by unfavorable volume/mix. The sales guidance also reflects a $15 million decline in contract manufacturing sales related to the divested pet food brands.

The decrease in adjusted EPS in Q2 is expected to be driven by a decrease in adjusted gross profit in US Retail Coffee, higher marketing investments, and the impact of divestitures. Adjusted EPS is anticipated to improve sequentially throughout the fiscal year.

SJM is expected to benefit from strength in its US Retail Coffee and Away From Home segments. The coffee segment is expected to benefit from higher pricing even though profits may be pressured by higher commodity costs. The Uncrustables brand is expected to continue its momentum in Frozen Handheld and Spreads along with the Meow-Mix brand in Pet Foods. However, pressures on discretionary income might impact dog snacks and sweet baked goods.

The company is working on product innovation, and it is focusing on high-return products while discontinuing products that are not performing to its expectations. These actions are expected to help reshape the portfolio and drive growth. The effects of these measures are likely to have benefited its performance in Q2 as well.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with renal diseases. In an email interview with AlphaStreet, CEO Dr.

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top